Examining IL-33 Expression in the Cervix of HPV-infected Patients: a Preliminary Study Comparing IL-33 Levels in Different Stages of Disease and Analyzing Its Potential Association with IFN-γ

Lei Wang,Hongying Li,Feng Liang,Yi Hong,Shaowei Jiang,Ling Xiao
DOI: https://doi.org/10.1007/s12032-014-0143-0
2014-01-01
Medical Oncology
Abstract:Research has shown the essential role of interleukin-33 (IL-33) in driving protective anti-viral immunity. IFN-γ has been reported to improve IL-33 expression in cultured epithelial cells. The development of cervical intraepithelial neoplasia (CIN) and carcinogenesis was closely related to human papilloma virus (HPV) infection and defective anti-viral immunity. The aim of this study was to investigate IL-33 expression alternation during the disease progress and its association with IFN-γ in HPV-positive patients. IL-33 was detected in endothelial cells and populations of epithelial cells in cervix. Though there was no statistically significant difference of IL-33 levels in cervical lavage and serum among different stages of disease ( P > 0.05), the IL-33 protein and mRNA levels in cervical tissues were significantly lower in severe CIN patients than that of mild CIN or no CIN patients ( P < 0.05). In addition, IL-33 protein levels were positively correlated with IFN-γ mRNA levels in all groups except cervical cancer (CA) group ( r = 0.546, P < 0.01). In vitro, IFN-γ was also found to upregulate IL-33 expression in human epidermal keratinocytes (NHEKs) in a dose-dependent manner. However, CA tissues did not show further reduced IL-33 protein and mRNA levels compared with severe CIN tissues ( P > 0.05). IFN-γ mRNA levels were even higher in CA tissues than in severe CIN tissues ( P < 0.05). Therefore, in cervical precancerous tissues, IL-33 levels were lower in more severe lesions and that may be related to diminished local IFN-γ.
What problem does this paper attempt to address?